Latha Vairavan, CFO of Arcutis Biotherapeutics ARQT, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $148.5K. The latest trade was on 05/11.

LV

LV

Latha Vairavan

SVP CFO

Company

Arcutis Biotherapeutics ARQT

First filing

25/05/07

Trades

11 trades

Buys / sales

0 / 7

12-month net buying

−$148.5K

Last trade

05/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Arcutis BiotherapeuticsARQT	Open-market sale10b5-1 plan	05/11	05/13	435 sh	$21.05	$9,156.75	−0.5%
Arcutis BiotherapeuticsARQT	Open-market sale10b5-1 plan	05/04	05/06	1,341 sh	$23.61	$31,661.01	−1.5%
Arcutis BiotherapeuticsARQT	Open-market sale10b5-1 plan	03/02	03/03	2,853 sh2 trades	$25.18avg.	$71,842.23	−3.1%
Arcutis BiotherapeuticsARQT	Open-market sale10b5-1 plan	02/02	02/04	1,320 sh	$25.50	$33,660	−2.0%
Arcutis BiotherapeuticsARQT	Open-market sale10b5-1 plan	25/11/03	25/11/05	88 sh	$24.72	$2,175.36	−0.1%
Arcutis BiotherapeuticsARQT	Open-market sale10b5-1 plan	25/08/04	25/08/05	89 sh	$14.33	$1,275.37	−0.1%